4 Trademark Results found for "REBLOZYL"

AU$

AU$AUD

$USD

Trademarks

About 4 Trademarks found for “REBLOZYL”

Filters

Also try searching for:

REBLOZYL*

REBL*

*ZYL

RE*YL

Details	Status	Class/Description
REBLOZYL Celgene Corporation 2394898 9 Oct 2023	Registered: Registered/protected	Pharmaceutical preparations for use in the treatment of anemia, beta t... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer.
REBLOZYL Celgene Corporation incorporated in the State of Delaware 2147114 6 Jan 2021	Registered: Registered/protected	Pharmaceutical preparations for use in the treatment of anemia, beta t... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer.
REBLOZYL Celgene Corporation 2090137 10 Mar 2020	Protected: Registered/protected	Pharmaceutical preparations for use in the treatment of anemia, beta t... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease and cancer.
REBLOZYL Celgene Corporation 1843749 14 Feb 2017	Protected: Registered/protected	Pharmaceutical preparations for use in the treatment of beta thalassem... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Registered: Registered/protected

REBLOZYL

Celgene Corporation

2394898 · 9 Oct 2023

005

Pharmaceutical preparations for use in the treatment of anemia, beta t...

Registered: Registered/protected

REBLOZYL

Celgene Corporation incorporated in the State of Delaware

2147114 · 6 Jan 2021

005

Pharmaceutical preparations for use in the treatment of anemia, beta t...

Protected: Registered/protected

REBLOZYL

Celgene Corporation

2090137 · 10 Mar 2020

005

Pharmaceutical preparations for use in the treatment of anemia, beta t...

Protected: Registered/protected

REBLOZYL

Celgene Corporation

1843749 · 14 Feb 2017

005

Pharmaceutical preparations for use in the treatment of beta thalassem...

Owners

Celgene corporation (3)

Celgene corporation inc.Orporated in the state of delaware (1)